Stock market performance

Welcome to the Euro-Nasdaq waltz

Read more

European biotechs narrowly ahead

Read more

Investors show caution about biotechs

Read more

Partial recovery of biotechs

Read more

2018 Fourth quarter stock market review

Read more

European biotechs pause during Q3

Read more

Biotechs in Q2: For now, the trend is down

Read more

European biotechs mixed in quarter

Read more

Why pharma is paying a premium for assets

Read more

The case for optimism for Europe's biotech sector

Read more